Federal grant · project grant (b)
Mapping the Marmoset: Characterizing the Impacts of Chimerism on Marmoset Development and Aging - Project Summary the Marmoset Monkey Has Emerged Recently as a Highly Tractable Nonhuman Primate Model of Aging. Marmosets Have Relatively Short Lifespans, and Exhibit Similar Aging-related Declines to Humans, Including Changes in Blood Pressure, Immune Function, and Cognition. However, There Is a Biological “black Box” in Marmoset Biology, the Implications of Which Few Researchers Mention. Marmosets Are Natural Chimeras, With Siblings Exchanging Genetic Material in Utero. Some Reports Limit Chimerism to Only Hematopoietic Tissues (e.g., Blood, Spleen, Bone Marrow) Whereas Others Suggest That Other Types of Tissue Can Be Chimeric, Including Germline Tissues, With Implications for Heritability. It Remains Unclear How the Presence of Multiple Genomes in an Individual Impacts Marmoset Physiology and the Risk of Age-related Morbidities. the Rationale for This Study Is That to Understand the Benefits and Limitations of the Marmoset Model We Must Characterize the Emergence and Impacts of Chimerism on an Individual. These Efforts Are Imperative to the Overall Objective of Being Able to Predict and Determine Outcomes of Chimerism. With the Increasing Appreciation That Chimerism in Humans Is Both Widespread and a Major Driver of Human Health, Marmoset Models of Chimerism May Be a Pivotal Tool in Aging Research. Therefore, the Specific Aims for This Proposal to 1) Define and Map Chimerism in Marmosets, 2) Characterize the Developmental Dynamics of Marmoset Chimerism, and 3) Evaluate the Costs of Chimerism for Aging Marmosets.
Committed
$336,731
Paid out
$313.4K
93%
Committed, not yet paid
$23.4K
7%
Everything here is this single award's whole record — signed, amended, paid — not a fiscal-year slice. The by-year charts elsewhere split an award across the years it was committed; this page keeps it whole.
Committed is what the government has legally promised on this award so far. Contracts can also carry a ceiling — the maximum if every option is exercised. Unspent ceiling is headroom, not money owed.
The cash actually disbursed against this award. The gap from committed is the disbursement pipeline: promised, not yet cashed.
Each transaction is a signing event — an action that created or changed the award, dated the day it was signed — not a payment. Negative amounts are real: money de-committed at closeout or renegotiation.
One bar, the award’s whole arithmetic: paid out, then committed, not yet paid, then .
Loading…